Structure-Guided Modification of Heterocyclic Antagonists of the P2Y 14 Receptor

Jinha Yu, Antonella Ciancetta, Steven Dudas, Sierra Duca, Justine Lottermoser, Kenneth A. Jacobson

Research output: Contribution to journalArticlepeer-review

28 Scopus citations


The P2Y 14 receptor (P2Y 14 R) mediates inflammatory activity by activating neutrophil motility, but few classes of antagonists are known. We have explored the structure-activity relationship of a 3-(4-phenyl-1H-1,2,3-triazol-1-yl)-5-(aryl)benzoic acid antagonist scaffold, assisted by docking and molecular dynamics (MD) simulation at a P2Y 14 R homology model. A computational pipeline using the High Throughput MD Python environment guided the analogue design. Selection of candidates was based upon ligand-protein shape and complementarity and the persistence of ligand-protein interactions over time. Predictions of a favorable substitution of a 5-phenyl group with thiophene and an insertion of a three-methylene spacer between the 5-aromatic and alkyl amino moieties were largely consistent with empirical results. The substitution of a key carboxylate group on the core phenyl ring with tetrazole or truncation of the 5-aryl group reduced affinity. The most potent antagonists, using a fluorescent assay, were a primary 3-aminopropyl congener 20 (MRS4458) and phenyl p-carboxamide 30 (MRS4478).

Original languageEnglish
Pages (from-to)4860-4882
Number of pages23
JournalJournal of Medicinal Chemistry
Issue number11
StatePublished - 14 Jun 2018

Bibliographical note

Publisher Copyright:
© 2018 by the American Chemical Society.


Dive into the research topics of 'Structure-Guided Modification of Heterocyclic Antagonists of the P2Y 14 Receptor'. Together they form a unique fingerprint.

Cite this